Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 6 (2009), Issue 8 (August)

1. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood.
   Hippocampus, 19(8): 763-72. [Abstract] [Full-text]
2. The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis.
   Addict Behav, 34(10): 821-5. [Abstract] [Full-text]
3. The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders.
   Addict Behav, 34(10): 852-8. [Abstract] [Full-text]
4. Reprint of "Treatment of cannabis use disorders in people with schizophrenia spectrum disorders--a systematic review".
   Addict Behav, 34(10): 846-51. [Abstract] [Full-text]
5. The BRAVE (Building Resiliency and Vocational Excellence) Program: evaluation findings for a career-oriented substance abuse and violence preventive intervention.
   J Health Care Poor Underserved, 20(3): 798-816. [Abstract] [Full-text]
6. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
   Neuropsychopharmacology, 34(9): 2072-80. [Abstract] [Full-text]
7. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".
   Dtsch Arztebl Int, 106(27): 464-7. [Abstract] [Full-text]
8. Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana.
   Exp Clin Psychopharmacol, 17(4): 217-25. [Abstract] [Full-text]
9. A population-based case-control study of marijuana use and head and neck squamous cell carcinoma.
   Cancer Prev Res (Phila Pa), 2(8): 759-68. [Abstract] [Full-text]
10. High HIV Prevalence Among Men Who have Sex with Men in Soweto, South Africa: Results from the Soweto Men's Study.
    AIDS Behav. [Abstract] [Full-text]
11. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
    Schizophr Res, 113(2): 129-37. [Abstract] [Full-text]
12. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.
    Schizophr Res, 113(2): 138-44. [Abstract] [Full-text]
13. Can recreational doses of THC produce significant dopamine release in the human striatum?
    Neuroimage, 48(1): 186-90. [Abstract] [Full-text]
14. Clinical and laboratory assessment of the subjective experience of drug craving.
    Clin Psychol Rev, 29(6): 519-34. [Abstract] [Full-text]
15. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.
    Schizophr Res, 113(2): 123-8. [Abstract] [Full-text]
16. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.
    J Hepatol, 51(3): 528-34. [Abstract] [Full-text]
17. Approach to treatment of mental illness and substance dependence in remote Indigenous communities: results of a mixed methods study.
    Aust J Rural Health, 17(4): 174-82. [Abstract] [Full-text]
18. Cannabinoid system in the skin - a possible target for future therapies in dermatology.
    Exp Dermatol, 18(8): 669-79. [Abstract] [Full-text]
19. First positive reactions to cannabis constitute a priority risk factor for cannabis dependence.
    Addiction. [Abstract] [Full-text]
20. Marijuana craving in the brain.
    Proc Natl Acad Sci U S A, 106(31): 13016-21. [Abstract] [Full-text]
21. Sleep architecture in adolescent marijuana and alcohol users during acute and extended abstinence.
    Addict Behav, 34(11): 976-9. [Abstract] [Full-text]
22. Negative affect, stress, and smoking in college students: unique associations independent of alcohol and marijuana use.
    Addict Behav, 34(11): 973-5. [Abstract] [Full-text]
23. A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood.
    Rapid Commun Mass Spectrom, 23(17): 2697-705. [Abstract] [Full-text]
24. Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs.
    Int J Legal Med. [Abstract] [Full-text]
25. Is universal prevention against youths' substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial.
    J Epidemiol Community Health, 63(9): 722-8. [Abstract] [Full-text]
26. Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.
    J Psychopharmacol, 23(7): 759-74. [Abstract] [Full-text]
27. Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.
    Psychiatr Q, 80(3): 143-54. [Abstract] [Full-text]
28. Elicitation studies in cell suspension cultures of Cannabis sativa L.
    J Biotechnol, 143(2): 157-68. [Abstract] [Full-text]
29. Racial/ethnic differences in correlates of prescription drug misuse among young adults.
    Drug Alcohol Depend, 104(3): 268-71. [Abstract] [Full-text]
30. Preventing growth in amphetamine use: long-term effects of the Midwestern Prevention Project (MPP) from early adolescence to early adulthood.
    Addiction. [Abstract] [Full-text]
31. The impact of childhood ADHD on dropping out of high school in urban adolescents/ young adults.
    J Atten Disord, 13(2): 127-36. [Abstract] [Full-text]
32. Cannabis Use and Sexual Health.
    J Sex Med. [Abstract] [Full-text]
33. Acute responses to nicotine and smoking: implications for prevention and treatment of smoking in lower SES women.
    Drug Alcohol Depend, 104: S79-86. [Abstract] [Full-text]
34. HIV sexual risk behaviors and perception of risk among college students: implications for planning interventions.
    BMC Public Health, 9: 281. [Abstract] [Full-text]
35. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.
    Nat Neurosci, 12(9): 1152-8. [Abstract] [Full-text]
36. Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan: findings from the World Mental Health Japan Survey 2002-2004.
    Soc Psychiatry Psychiatr Epidemiol, 44(9): 777-83. [Abstract] [Full-text]
37. Antenatal environmental stress and maturation of the breathing control, experimental data.
    Respir Physiol Neurobiol, 168(1): 92-100. [Abstract] [Full-text]
38. Altered white matter microstructure in adolescent substance users.
    Psychiatry Res, 173(3): 228-37. [Abstract] [Full-text]
39. First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group.
    Soc Psychiatry Psychiatr Epidemiol, 44(9): 710-5. [Abstract] [Full-text]
40. Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.
    Glia, 57(13): 1374-85. [Abstract] [Full-text]
41. A qualitative and quantitative HPTLC densitometry method for the analysis of cannabinoids in Cannabis sativa L.
    Phytochem Anal, 20(5): 421-6. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.